A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IPMNs / intraductal papillary mucinous neoplasms

[Related PubMed/MEDLINE]
Total Number of Papers: 473
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IPMNs  (>> Co-occurring Abbreviation)
Long Form:   intraductal papillary mucinous neoplasms
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT. CI, HRS, ICG, NPV, OR, PPV, WFs
2020 Comparison of imaging modalities for measuring the diameter of intraductal papillary mucinous neoplasms of the pancreas. CT, EUS, LOA, MRI
2020 Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms. OR
2020 Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms. ---
2020 EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video). AUC, CI, HGD-Ca, IOA, LGD, nCLE
2020 Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. ---
2020 Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas. HGD, HRS, LGD, OR
2020 Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas. MPD
2020 Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. PDAC, SHRs
10  2020 Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. HGD, MDMs, PDACs
11  2020 Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm. AIP
12  2020 Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. AUC, CFIM, CT, QI, TANs
13  2020 Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy. CT, ICG
14  2020 Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids. cf, MCNs, PCFs, SCNs
15  2020 Noninvasive Discrimination of Low and High-risk Pancreatic Intraductal Papillary Mucinous Neoplasms. ---
16  2020 Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines. CI, DSS, HR, RFS
17  2020 Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: The "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis. Brief-COPE, BSMSS, PSS
18  2020 Pylorus-Preserving Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm in the Setting of Previous Roux-en-Y Cystjejunostomy for Pancreatic Pseudocyst. ---
19  2020 Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas. CA19-9, CEA, HGD, INV, S-p53Ab
20  2020 Stratifying Intraductal Papillary Mucinous Neoplasms by Cyst Fluid Analysis: Present and Future. ---
21  2020 Surgical strategy forintraductal papillary mucinous neoplasms ofthepancreas. HGD, IPMC
22  2020 The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas. FDG, ICG, PET, PRISMA
23  2019 A Consensus Study of the Grading and Typing of Intraductal Papillary Mucinous Neoplasms of the Pancreas. ---
24  2019 Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data. DSS, IPMN
25  2019 Age-related morphological changes in the pancreas and their association with pancreatic carcinogenesis. PanIN, PDAC
26  2019 Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia. ---
27  2019 Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms. ---
28  2019 Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm. IPNBs
29  2019 Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. ---
30  2019 Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium. HGD, HRS, IC, WF
31  2019 Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review. AUC
32  2019 Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines. IPMN
33  2019 Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression. ---
34  2019 Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer. CT, EUS, MRI
35  2019 Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. IL, PCN, PPI
36  2019 GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. EGFR
37  2019 Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. BD, EUROPAC, FPC, IQR, PDAC
38  2019 Increased Risk of Second Primary Cancers Following Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Population-Based Study. CI, HRs, RR, SEER, SIR, SPCs
39  2019 Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms. BP, HG, LG
40  2019 Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. HGD, LGD, PCNs, SCN
41  2019 Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. ---
42  2019 Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery. CI, HGD, MD, MNs, MPD, OR
43  2019 Malignant conversion and peritoneal dissemination after endoscopic ultrasound-guided ethanol ablation in intraductal papillary mucinous neoplasm of the pancreas. EUS-PCA
44  2019 Management and outcomes of intraductal papillary mucinous neoplasms. BD, DSS, MD, MT, PDAC
45  2019 MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms. MRCP, MRI
46  2019 Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas. HGD, IGD, LGD, NLR, PNI
47  2019 Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. NLR
48  2019 Obstructive cholangitis by mucus from an intraductal papillary mucinous neoplasm with pancreatobiliary fistula treated by endoscopic septotomy and direct peroral cholangioscopy: a case report. CT, ERCP
49  2019 Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. PDAs
50  2019 Pitfalls of histopathological evaluation of EUS-guided microbiopsies from pancreatic cystic neoplasms. SCNs
51  2019 Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. BD-IPMN
52  2019 Prevalence of Asymptomatic Intraductal Papillary Mucinous Neoplasms in Healthy and Ill Populations Detected by Ultrasonography: A Single-Center Study of 6353 Outpatients. HRS, OR, WF
53  2019 Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. ---
54  2019 Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. ---
55  2019 Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. HGD-IPMN, LGD-IPMNs, PDAC
56  2019 Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry. PDAC
57  2019 Subtyping of IPMN. ---
58  2019 Talking Genes in Breast and Pancreatic Malignancies. FPC, PDAC
59  2019 Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. PDAC
60  2019 The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas. MPD
61  2019 Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. AI, EUS
62  2019 Validation of Indications for Surgery of European Evidence-Based Guidelines for Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms. DM, EEBGPCN, HGD, IC
63  2019 What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study. HRS
64  2018 A case of intraductal papillary-mucinous neoplasm of the pancreas penetrating into the stomach and spleen successfully treated by total pancreatectomy. CT, IPMC
65  2018 A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. PDAC
66  2018 Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort. ICCs, LOA
67  2018 ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma inMice. ATP, PanINs, PDACs, PDCs
68  2018 Cells of origin of pancreatic neoplasms. MCNs, PanINs, PDAC
69  2018 Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome. GI, MAS, MRCP
70  2018 Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection. CS, MD, PD, SEER, UD, WD
71  2018 CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas. AUC, BD
72  2018 Curative resection of pancreatic ductal adenocarcinoma developing in the remnant pancreas 13 years after distal pancreatectomy for intraductal papillary mucinous neoplasms: A case report. PDAC
73  2018 Cyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the Pancreas. MCNs
74  2018 Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. BD
75  2018 Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study. ---
76  2018 Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms. MPD
77  2018 GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. PDACs, YAP
78  2018 Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms. HGD, IHC, LGD
79  2018 Imaging Follow-up of Low-Risk Incidental Pancreas and Kidney Findings: Effects of Patient Age and Comorbidity on Projected Life Expectancy. LE, SB
80  2018 Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms. CECs
81  2018 Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes. ---
82  2018 Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. ---
83  2018 Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. ---
84  2018 IPMNs with co-occurring invasive cancers: neighbours but not always relatives. ---
85  2018 Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice. PDACs
86  2018 Mass Spectrometry-Based Comprehensive Analysis of Pancreatic Cyst Fluids. CAs, MCNs, PCFs, PCLs, PCs, SCNs
87  2018 Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation. ---
88  2018 Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. GNAS, PDAs
89  2018 Pancreatic Cancer Cell Fraction Estimation in a DNA Sample. ---
90  2018 Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm. PDACs
91  2018 Pancreatobiliary fistula associated with intraductal papillary mucinous carcinoma accompanying obstructive jaundice: A case report. ---
92  2018 Precursor Lesions of Pancreatic Cancer. IOPNs, ITPNs, MCNs, PanINs, PDAC
93  2018 Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort. ---
94  2018 Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. EUS, MCNs, NGS, PCF, PCs
95  2018 Prevalence of Extrapancreatic Malignancies Among Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. CI, EPMs
96  2018 Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms. HGD, LGD
97  2018 Significance of microcystic, elongated, and fragmented glandular-like features in intraductal papillary mucinous neoplasm of the pancreas. MELF
98  2018 Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. HGD
99  2018 Surgical Treatment of a Mucinous Cystic Neoplasm in a Young Female Patient - A Case Report. MCNs, SCTs, SPNs
100  2018 The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management. DSS, HRS, OS